1. Home
  2. GLXG vs MTVA Comparison

GLXG vs MTVA Comparison

Compare GLXG & MTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLXG
  • MTVA
  • Stock Information
  • Founded
  • GLXG 2013
  • MTVA 2014
  • Country
  • GLXG Hong Kong
  • MTVA United States
  • Employees
  • GLXG N/A
  • MTVA N/A
  • Industry
  • GLXG
  • MTVA
  • Sector
  • GLXG
  • MTVA
  • Exchange
  • GLXG NYSE
  • MTVA NYSE
  • Market Cap
  • GLXG 17.7M
  • MTVA 16.8M
  • IPO Year
  • GLXG 2024
  • MTVA N/A
  • Fundamental
  • Price
  • GLXG $0.98
  • MTVA $1.74
  • Analyst Decision
  • GLXG
  • MTVA Strong Buy
  • Analyst Count
  • GLXG 0
  • MTVA 1
  • Target Price
  • GLXG N/A
  • MTVA $12.00
  • AVG Volume (30 Days)
  • GLXG 3.3M
  • MTVA 57.9K
  • Earning Date
  • GLXG 02-16-2025
  • MTVA 03-27-2025
  • Dividend Yield
  • GLXG N/A
  • MTVA N/A
  • EPS Growth
  • GLXG N/A
  • MTVA N/A
  • EPS
  • GLXG 0.04
  • MTVA N/A
  • Revenue
  • GLXG $3,858,088.00
  • MTVA N/A
  • Revenue This Year
  • GLXG N/A
  • MTVA N/A
  • Revenue Next Year
  • GLXG N/A
  • MTVA N/A
  • P/E Ratio
  • GLXG $22.24
  • MTVA N/A
  • Revenue Growth
  • GLXG N/A
  • MTVA N/A
  • 52 Week Low
  • GLXG $0.70
  • MTVA $1.51
  • 52 Week High
  • GLXG $16.93
  • MTVA $6.75
  • Technical
  • Relative Strength Index (RSI)
  • GLXG N/A
  • MTVA N/A
  • Support Level
  • GLXG N/A
  • MTVA N/A
  • Resistance Level
  • GLXG N/A
  • MTVA N/A
  • Average True Range (ATR)
  • GLXG 0.00
  • MTVA 0.00
  • MACD
  • GLXG 0.00
  • MTVA 0.00
  • Stochastic Oscillator
  • GLXG 0.00
  • MTVA 0.00

About GLXG GALAXY PAYROLL GROUP LTD

Galaxy Payroll Group Ltd provides payroll outsourcing, employment, consultancy, and market research services based in Hong Kong. Its client base includes retail, trading, industrial, IT, financial, and professional services industries. Geographically, the company derives maximum revenue from its clients in the People's Republic of China and the rest from Hong Kong, Macau, Taiwan, Japan, Thailand, Singapore, and other countries.

About MTVA METAVIA INC

MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.

Share on Social Networks: